These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG. J Gen Virol; 1991 Dec; 72 ( Pt 12)():3025-33. PubMed ID: 1662694 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887 [Abstract] [Full Text] [Related]
4. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G. J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924 [Abstract] [Full Text] [Related]
5. Molecular size variation of EBNA is determined by the EB viral genome. Gergely L, Sternås L, Dillner J, Klein G. Intervirology; 1984 Jul; 22(2):85-96. PubMed ID: 6090339 [Abstract] [Full Text] [Related]
6. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB. J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672 [Abstract] [Full Text] [Related]
7. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H. Int J Cancer; 1993 Feb 20; 53(4):621-7. PubMed ID: 8382194 [Abstract] [Full Text] [Related]
8. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dölken G. Blood; 1992 Jul 15; 80(2):459-69. PubMed ID: 1378321 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Cohen JI, Wang F, Kieff E. J Virol; 1991 May 15; 65(5):2545-54. PubMed ID: 1850028 [Abstract] [Full Text] [Related]
10. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection. Contreras-Salazar B, Ehlin-Henriksson B, Klein G, Masucci MG. J Virol; 1990 Nov 15; 64(11):5441-7. PubMed ID: 2170681 [Abstract] [Full Text] [Related]
11. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. Cuomo L, Trivedi P, de Campos-Lima PO, Zhang QJ, Ragnar E, Klein G, Masucci MG. Mol Immunol; 1993 Apr 15; 30(5):441-50. PubMed ID: 7681932 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, Wang F, Rymo L, Rickinson AB. J Virol; 1990 May 15; 64(5):2126-34. PubMed ID: 2157875 [Abstract] [Full Text] [Related]
13. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells. Doyle MG, Crawford DH. Intervirology; 1994 May 15; 37(5):236-44. PubMed ID: 7698878 [Abstract] [Full Text] [Related]
14. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G. J Virol; 1987 Dec 15; 61(12):3870-8. PubMed ID: 2824821 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ, Crawford DH, Thomas JA. J Gen Virol; 1993 Mar 15; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [Abstract] [Full Text] [Related]
16. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region. Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I. J Virol; 1991 Mar 15; 65(3):1558-67. PubMed ID: 1847471 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E. Proc Natl Acad Sci U S A; 1987 May 15; 84(10):3452-6. PubMed ID: 3033649 [Abstract] [Full Text] [Related]
19. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. Kis LL, Takahara M, Nagy N, Klein G, Klein E. Blood; 2006 Apr 01; 107(7):2928-35. PubMed ID: 16332968 [Abstract] [Full Text] [Related]
20. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR. Eur J Immunol; 1995 May 01; 25(5):1374-84. PubMed ID: 7774641 [Abstract] [Full Text] [Related] Page: [Next] [New Search]